{"id":52114,"date":"2022-12-19T11:02:46","date_gmt":"2022-12-19T10:02:46","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/topical-drug-delivery-global-market-to-reach-186-51-billion-by-2026-at-a-cagr-of-8-researchandmarkets-com\/"},"modified":"2022-12-19T11:02:46","modified_gmt":"2022-12-19T10:02:46","slug":"topical-drug-delivery-global-market-to-reach-186-51-billion-by-2026-at-a-cagr-of-8-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/topical-drug-delivery-global-market-to-reach-186-51-billion-by-2026-at-a-cagr-of-8-researchandmarkets-com\/","title":{"rendered":"Topical Drug Delivery Global Market to Reach $186.51 Billion by 2026 at a CAGR of 8% – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Topical Drug Delivery Global Market Report 2022: Ukraine-Russia War Impact”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global topical drug delivery market is expected to grow from $126.11 billion in 2021 to $137.15 billion in 2022 at a compound annual growth rate (CAGR) of 8.8%. The topical drug delivery market is expected to grow to $186.51 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%.\n<\/p>\n

\nNorth America was the largest region in the topical drug delivery market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.\n<\/p>\n

\nThe growing prevalence of diabetes is expected to propel the growth of the topical drug delivery market going forward. Diabetes is a group of diseases that affect how the body uses blood sugar and results in high blood sugar levels. Topical drug delivery helps diabetes patients by administering medicines that can bypass hepatic first-pass metabolism. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, diabetes was the ninth leading cause of death in 2019, with an estimated 1.5 million deaths directly caused by diabetes. Therefore, the growing prevalence of diabetes is driving the growth of the topical drug delivery market.\n<\/p>\n

\nTechnological advancement is a key trend gaining popularity in the topical drug delivery market. Major companies operating in the topical drug delivery market are developing innovative products with advanced technologies to strengthen their position in the topical drug delivery market.\n<\/p>\n

\nFor instance, in April 2022, Sol-Gel Technologies Ltd., an Israel-based dermatology company, and Galderma S.A., a Switzerland-based pharmaceutical company specializing in dermatological treatments and skin care products, introduced Epsolay (benzoyl peroxide, cream, 5%), utilizing Sol-Gel’s microencapsulation technology for the treatment of inflammatory lesions of rosacea, which is patent protected until 2040. Sol-gel microencapsulation provides the advantage of entrapping molecules by forming inclusion complexes between essential oils (Eos) as guest molecules and beta-cyclodextrin as host in porous silica, making it more stable and resistant to environmental conditions. Silica acts as a protector for EOs.\n<\/p>\n

\nThe countries covered in the topical drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.\n<\/p>\n

\nReasons to Purchase<\/strong>\n<\/p>\n